Autologous stem cell transplantation in patients who object to a blood transfusion: contribution of new pharmacological haematopoiesis support. (öffnet neues Fenster)

Al-Nawakil C, Quarre MC, Heshmati F, Deau B, Park S, Dreyfus F, Bouscary D, Tamburini J.

Quelle‎: Br J Haematol 2013;161(5):738-40.

Indiziert‎: PubMed 23480574

DOI‎: 10.1111/bjh.12284

https://www.ncbi.nlm.nih.gov/pubmed/23480574 (öffnet neues Fenster)

Autologous stem-cell transplantation can be performed safely without the use of blood-product support. (öffnet neues Fenster)

Ballen KK, Becker PS, Yeap BY, Matthews B, Henry DH, Ford PA.

Quelle‎: J Clin Oncol 2004;22(20):4087-94.

Indiziert‎: PubMed 15353543

DOI‎: 10.1200/JCO.2004.01.144

https://www.ncbi.nlm.nih.gov/pubmed/15353543 (öffnet neues Fenster)

Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients. (öffnet neues Fenster)

Beck A, Lin R, Reza Rejali A, Rubens M, Paquette R, Vescio R, Merin N, Guerrero M, Federizo Y, Lua M, Uy L, Hernandez L, Allred M, Legaspi R, Leaverton M, Oliva S, Castillo R, Dean L, Bourke J, Cooper S, Gharapetian S, Causin J, Lopiccolo C, Ann Snoussi L, VanStrien P, Lill M, Linhares YP

Quelle‎: Bone Marrow Transplant 2020;55(6):1059-67.

Indiziert‎: PubMed 31898692

DOI‎: 10.1038/s41409-019-0777-9

https://www.ncbi.nlm.nih.gov/pubmed/31898692 (öffnet neues Fenster)

The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood products. (öffnet neues Fenster)

Ciurea S, Beri R, Dobogai L, Chunduri S, Mahmud N, Rondelli D, Peace D.

Quelle‎: Bone Marrow Transplant 2006;37(3):325-7.

Indiziert‎: PubMed 16314850

DOI‎: 10.1038/sj.bmt.1705223

https://www.ncbi.nlm.nih.gov/pubmed/16314850 (öffnet neues Fenster)

Hematopoietic stem cell transplantation without the use of blood components by the patient's choice: experience of 2 Brazilian centers. (öffnet neues Fenster)

da Silva RL, da Silva LAM, Geraldo BLDSS, Simões AA, Almeida MSS, Fernandes PA, Simões CM, Russo FT, Okada LY, Cavalcante JN, Lopes MAVF, Macedo RA, Macedo MCMA

Quelle‎: Biol Blood Marrow Transplant 2020;26(3):458-62.

Indiziert‎: PubMed 31669397

DOI‎: 10.1016/j.bbmt.2019.10.018

https://www.ncbi.nlm.nih.gov/pubmed/31669397 (öffnet neues Fenster)

Transfusion challenges in hematology oncology and hematopoietic stem cell transplant - literature review and local experience. (öffnet neues Fenster)

Elemary M, Seghatchian J, Stakiw J, Bosch M, Sabry W, Goubran H

Quelle‎: Transfus Apher Sci 2017;56(3):317-21.

Indiziert‎: PubMed 28642120

DOI‎: 10.1016/j.transci.2017.05.022

https://www.ncbi.nlm.nih.gov/pubmed/28642120 (öffnet neues Fenster)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (öffnet neues Fenster)

Ford PA, Grant SJ, Mick R, Keck G.

Quelle‎: J Clin Oncol 2015;33(15):1674-9.

Indiziert‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (öffnet neues Fenster)

Myeloablative chemotherapy and autologous stem cell transplantation without the use of blood products. (öffnet neues Fenster)

Jamal F, Lim SW, Vescio R, Pepkowitz S, Van Strien P, Hoshal K, Lill MC.

Quelle‎: Biol Blood Marrow Transplant 2005;11(2 Suppl 1):66-7.

DOI‎: 10.1016/j.bbmt.2004.12.199

http://www.bbmt.org/article/S1083-8791(04)00851-1/fulltext (öffnet neues Fenster)

Safety and survival outcomes for bloodless transplantation in patients with myeloma. (öffnet neues Fenster)

Joseph NS, Kaufman JL, Boise LH, Valla K, Almaula DK, Obidike CO, Langston AA, Waller EK, Khoury HJ, Flowers CR, Graiser M, Heffner LT, Lonial S, Nooka AK

Quelle‎: Cancer 2019;125(2):185-93.

Indiziert‎: PubMed 30480777

DOI‎: 10.1002/cncr.31677

https://www.ncbi.nlm.nih.gov/pubmed/30480777 (öffnet neues Fenster)

Bloodless tandem autologous transplant in Jehovah's Witness patients. (öffnet neues Fenster)

Khan R, Mott SL, Schultz A, Jethava YS, Tricot G

Quelle‎: Bone Marrow Transplant 2018. [Epub ahead of print]

Indiziert‎: PubMed 29795417

DOI‎: 10.1038/s41409-018-0132-6

https://www.ncbi.nlm.nih.gov/pubmed/29795417 (öffnet neues Fenster)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (öffnet neues Fenster)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Quelle‎: Bone Marrow Transplant 2003;32(4):433-6.

Indiziert‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (öffnet neues Fenster)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (öffnet neues Fenster)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Quelle‎: Bone Marrow Transplant 2005;36(8):715-20.

Indiziert‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (öffnet neues Fenster)

SCT in Jehovah's Witnesses: the bloodless transplant. (öffnet neues Fenster)

Sloan JM, Ballen K.

Quelle‎: Bone Marrow Transplant 2008;41(10):837-44.

Indiziert‎: PubMed 18246110

DOI‎: 10.1038/bmt.2008.5

https://www.ncbi.nlm.nih.gov/pubmed/18246110 (öffnet neues Fenster)